Overseed: Funding, Investors & Team (Aug 2026)
Overseed is a biotechnology firm that specializes in researching and developing pharmaceutical uses for the cannabis plant. By integrating genetics, agronomy, and the chemical properties of natural and pharmaceutical compounds, Overseed aims to optimize the production of therapeutic cannabis. The company is dedicated to exploring the medical potential of cannabinoids and provides dried flowers, full spectrum extracts, and pharmaceutical-grade purified active ingredients for laboratory use.
Overseed has raised $7.2M across 1 funding round on record, the most recent a Series A of $7.2M announced in Jul 2024.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Overseed Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Overseed Funding Rounds
Overseed Founders and Leadership Team
No contact details are on record for this team yet.
Overseed Funding Compared to Other Biotechnology Startups
Overseed's latest round of $7.2M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Overseed in Biotechnology and Orléans
Companies Similar to Overseed
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Overseed Funding FAQs
What does Overseed do?
Overseed is a biotechnology firm that specializes in researching and developing pharmaceutical uses for the cannabis plant. By integrating genetics, agronomy, and the chemical properties of natural and pharmaceutical compounds, Overseed aims to optimize the production of therapeutic cannabis. The company is dedicated to exploring the medical potential of cannabinoids and provides dried flowers, full spectrum extracts, and pharmaceutical-grade purified active ingredients for laboratory use.
How much funding has Overseed raised?
Overseed has raised $7.2M across 1 round on record. The most recent is a Series A of $7.2M announced in Jul 2024.
When did Overseed last raise funding?
Overseed's most recent funding round on record is a Series A of $7.2M, announced in Jul 2024.
Who founded Overseed?
FundedIQ lists Hugues Peribere (Founder) at Overseed.
Where is Overseed headquartered?
Overseed is based in Orléans, Centre, France.
How many employees does Overseed have?
Overseed is in the 1-10 employee band.
How does Overseed's funding compare to other Biotechnology startups?
Overseed's latest round of $7.2M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Overseed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Overseed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.